New Delhi, June 24 -- India is moving to cut off supplies of critical IVF media, reagents and laboratory consumables to unregistered fertility clinics, in a regulatory crackdown aimed at curbing unauthorized reproductive healthcare in the country.

The directive, issued by the country's apex drug and medical device regulator, the Drugs Controller General of India (DCGI), follows concerns that sensitive medical devices are being supplied to unverified, non-compliant medical facilities across the country.

In a circular dated 23 June, DCGI Rajeev Raghuvanshi directed states/UTs and zonal and sub-zonal offices of the Central Drugs Standard Control Organisation (CDSCO) to strengthen ground-level monitoring and ensure that non-registered centr...